UnitedHealth : Reports Second Quarter 2022 Results - Form 8-K
July 15, 2022 at 06:44 am EDT
Share
UnitedHealth Group Reports Second Quarter 2022 Results
•Revenues of $80.3 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare
•Earnings from Operations were $7.1 Billion, Growth of 19% Year-Over-Year
•Cash Flows from Operations were $6.9 Billion, 1.3x Net Income
•Earnings were $5.34 Per Share, Adjusted Earnings $5.57 Per Share
MINNETONKA, Minn. (July 15, 2022) - UnitedHealth Group (NYSE: UNH) reported second quarter 2022 performance led by broad-based growth at Optum and UnitedHealthcare.
"Customers are responding as we build on our five growth pillars, enabling us to move into the second half of 2022 with strong momentum serving ever more people more deeply," said Andrew Witty, chief executive officer of UnitedHealth Group.
Based upon the first half performance and growth expectations, the company increased its full year net earnings outlook to $20.45 to $20.95 per share and adjusted net earnings to $21.40 to $21.90 per share. Growth in the second quarter was balanced across the company's businesses, driven especially by continued strong expansion in people served at UnitedHealthcare and in value-based arrangements at Optum Health.
Page 1 of 6
Quarterly Financial Performance
Three Months Ended
June 30,
June 30,
March 31,
2022
2021
2022
Revenues
$80.3 billion
$71.3 billion
$80.1 billion
Earnings from Operations
$7.1 billion
$6.0 billion
$7.0 billion
Net Margin
6.3%
6.0%
6.3%
•UnitedHealth Group's second quarter 2022 revenues grew $9 billion or 13% to $80.3 billion year-over-year, reflecting double-digit growth at both Optum and UnitedHealthcare.
•Second quarter 2022 earnings from operations were $7.1 billion with well-diversified contributions from across the enterprise. Adjusted net earnings of $5.57 per share increased 19% year-over-year.
•The second quarter 2022 medical care ratio was 81.5% compared to 82.8% last year, due to COVID effects and business mix. Favorable medical reserve development of $890 million compared to $500 million in the year ago second quarter. Days claims payable were 50.6, compared to 49.1 in the first quarter of 2022 and the second quarter of 2021.
•The second quarter 2022 operating cost ratio of 14.6% compares to 14.5% in 2021, reflecting continued productivity gains, offset by business mix and the investments the company continues to make to support future growth opportunities.
•Cash flows from operations for the second quarter 2022 were $6.9 billion or 1.3-times net income. The company returned $4 billion to shareholders in the second quarter through dividends and share repurchases and increased the dividend by 14% in June 2022. Return on equity of 27.9% in the quarter reflected the company's sustained earnings growth profile and efficient capital structure.
Page 2 of 6
UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value customers and consumers receive by improving health and wellness, enhancing the quality of care received, simplifying the health care experience and reducing the total cost of care.
Quarterly Financial Performance
Three Months Ended
June 30,
June 30,
March 31,
2022
2021
2022
Revenues
$62.1 billion
$55.5 billion
$62.6 billion
Earnings from Operations
$3.9 billion
$3.1 billion
$3.8 billion
Operating Margin
6.2%
5.6%
6.1%
•UnitedHealthcare second quarter revenues of $62.1 billion grew $6.6 billion or 12% year-over-year, reflecting broad-based growth.
•Second quarter 2022 operating earnings were $3.9 billion compared to $3.1 billion last year, reflecting strong growth in people served and continued medical and operating cost management.
•Total people served by UnitedHealthcare has grown by over 600,000 in 2022, including 280,000 in the second quarter. Growth was led by UnitedHealthcare's community-based and senior offerings. The number of people served with domestic commercial benefit offerings has grown by over 250,000 over the past year, including 80,000 in the second quarter.
Page 3 of 6
Optum's health services businesses serve the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using market-leading information, analytics, technology and clinical insights, Optum helps improve overall health system performance: optimizing care quality, reducing care costs and improving the consumer experience.
Quarterly Financial Performance
Three Months Ended
June 30,
June 30,
March 31,
2022
2021
2022
Revenues
$45.1 billion
$38.3 billion
$43.3 billion
Earnings from Operations
$3.3 billion
$2.9 billion
$3.2 billion
Operating Margin
7.3%
7.5%
7.3%
•Optum second quarter revenues of $45.1 billion grew $6.8 billion or 18% year-over-year, with double-digit growth at each business, led by Optum Health. Operating earnings were $3.3 billion compared to $2.9 billion last year.
•Optum Health revenue per consumer served increased 30% over the year ago period, driven by growth in the number of people served under value-based care arrangements and continued expansion of the care services offered, including in-home, digital, clinic-based and outpatient services.
•Optum Insight's revenue backlog increased by $2.3 billion to $23.6 billion compared to a year ago. Growth was driven by comprehensive managed services for health systems and an expanding suite of information technology and data analytics offerings.
•Optum Rx's revenue growth of 10% in the second quarter reflects continued success in serving new clients as well as further expansion of pharmacy care services offerings, including specialty and community pharmacy. Adjusted scripts grew to 357 million compared to 342 million last year.
Page 4 of 6
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow @UnitedHealthGrp on Twitter.
Earnings Conference Call
As previously announced, UnitedHealth Group will discuss the company's results, strategy and future outlook on a conference call with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company's website (www.unitedhealthgroup.com). Following the call, a webcast replay will be available on the same site through July 29, 2022. The conference call replay can also be accessed by dialing 1-888-203-1112, Conference Code: 5961010. This earnings release and the Form 8-K dated July 15, 2022, can also be accessed from the Investor Relations page of the company's website.
Non-GAAP Financial Information
This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.
Forward-Looking Statements
The statements, estimates, projections, guidance or outlook contained in this document include "forward-looking" statements which are intended to take advantage of the "safe harbor" provisions of the federal securities law. The words "believe," "expect," "intend," "estimate," "anticipate," "forecast," "outlook," "plan," "project," "should" and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic; our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; the DOJ's legal action relating to the risk
Page 5 of 6
adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; failure to protect proprietary rights to our databases, software and related products; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to develop and deliver innovative products to health care payers and expand access to virtual care; changes in or challenges to our public sector contract awards; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; failure to attract, develop, retain, and manage the succession of key employees and executives; the impact of potential changes in tax laws and regulations (including any increase in the U.S. income tax rate applicable to corporations); failure to achieve targeted operating cost productivity improvements; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to manage successfully our strategic alliances or complete or receive anticipated benefits of strategic transactions; fluctuations in foreign currency exchange rates; downgrades in our credit ratings; our investment portfolio performance; impairment of our goodwill and intangible assets; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.
# # #
Investor Contact:
Media Contact:
Zack Sopcak
Matt Stearns
Senior Vice President
Senior Vice President
952-936-7215
202-276-0085
zack.sopcak@uhg.com
matt.stearns@uhg.com
Page 6 of 6
UNITEDHEALTH GROUP
Earnings Release Schedules and Supplementary Information
Quarter Ended June 30, 2022
•Condensed Consolidated Statements of Operations
•Condensed Consolidated Balance Sheets
•Condensed Consolidated Statements of Cash Flows
•Supplemental Financial Information - Businesses
•Supplemental Financial Information - Business Metrics
•Reconciliation of Non-GAAP Financial Measure
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)
(unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2022
2021
2022
2021
Revenues
Premiums
$63,896
$56,233
$127,966
$111,719
Products
9,496
8,433
18,836
16,773
Services
6,645
6,099
13,017
12,017
Investment and other income
295
556
662
1,008
Total revenues
80,332
71,321
160,481
141,517
Operating costs
Medical costs
52,093
46,546
104,616
91,450
Operating costs
11,709
10,359
23,110
20,582
Cost of products sold
8,596
7,660
17,083
15,232
Depreciation and amortization
802
778
1,590
1,536
Total operating costs
73,200
65,343
146,399
128,800
Earnings from operations
7,132
5,978
14,082
12,717
Interest expense
(467)
(410)
(900)
(807)
Earnings before income taxes
6,665
5,568
13,182
11,910
Provision for income taxes
(1,466)
(1,196)
(2,835)
(2,560)
Net earnings
5,199
4,372
10,347
9,350
Earnings attributable to noncontrolling interests
(129)
(106)
(250)
(222)
Net earnings attributable to UnitedHealth Group common shareholders
$5,070
$4,266
$10,097
$9,128
Diluted earnings per share attributable to UnitedHealth Group common shareholders
$5.34
$4.46
$10.61
$9.55
Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)
$5.57
$4.70
$11.06
$10.02
Diluted weighted-average common shares outstanding
950
956
952
956
(a)See page 6 for a reconciliation of the non-GAAP measure
1
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
(unaudited)
June 30,
2022
December 31,
2021
Assets
Cash and short-term investments
$27,964
$23,907
Accounts receivable, net
18,718
14,216
Other current assets
21,674
23,635
Total current assets
68,356
61,758
Long-term investments
42,427
43,114
Other long-term assets
119,389
107,334
Total assets
$230,172
$212,206
Liabilities, redeemable noncontrolling interests and equity
Medical costs payable
$28,978
$24,483
Short-term borrowings and current maturities of long-term debt
5,592
3,620
Other current liabilities
54,128
50,189
Total current liabilities
88,698
78,292
Long-term debt, less current maturities
45,799
42,383
Other long-term liabilities
14,548
15,052
Redeemable noncontrolling interests
4,922
1,434
Equity
76,205
75,045
Total liabilities, redeemable noncontrolling interests and equity
$230,172
$212,206
2
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
Six Months Ended
June 30,
2022
2021
Operating Activities
Net earnings
$10,347
$9,350
Noncash items:
Depreciation and amortization
1,590
1,536
Deferred income taxes and other
200
113
Share-based compensation
504
426
Net changes in operating assets and liabilities
(451)
120
Cash flows from operating activities
12,190
11,545
Investing Activities
Purchases of investments, net of sales and maturities
(3,366)
(2,789)
Purchases of property, equipment and capitalized software
(1,212)
(1,130)
Cash paid for acquisitions, net
(7,150)
(4,642)
Other, net
(532)
(648)
Cash flows used for investing activities
(12,260)
(9,209)
Financing Activities
Common share repurchases
(5,000)
(2,900)
Dividends paid
(2,908)
(2,548)
Net change in short-term borrowings and long-term debt
6,162
4,858
Other, net
4,996
1,159
Cash flows from financing activities
3,250
569
Effect of exchange rate changes on cash and cash equivalents
57
6
Increase in cash and cash equivalents
3,237
2,911
Cash and cash equivalents, beginning of period
21,375
16,921
Cash and cash equivalents, end of period
$24,612
$19,832
3
UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES
(in millions, except percentages)
(unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2022
2021
2022
2021
Revenues
UnitedHealthcare
$62,105
$55,474
$124,700
$110,588
Optum
45,082
38,303
88,341
74,687
Eliminations
(26,855)
(22,456)
(52,560)
(43,758)
Total consolidated revenues
$80,332
$71,321
$160,481
$141,517
Earnings from Operations
UnitedHealthcare
$3,850
$3,095
$7,648
$7,203
Optum (a)
3,282
2,883
6,434
5,514
Total consolidated earnings from operations
$7,132
$5,978
$14,082
$12,717
Operating Margin
UnitedHealthcare
6.2
%
5.6
%
6.1
%
6.5
%
Optum
7.3
%
7.5
%
7.3
%
7.4
%
Consolidated operating margin
8.9
%
8.4
%
8.8
%
9.0
%
Revenues
UnitedHealthcare Employer & Individual - Domestic
$15,567
$14,942
$31,389
$29,574
UnitedHealthcare Employer & Individual - Global
2,247
2,118
4,380
4,153
UnitedHealthcare Employer & Individual - Total
17,814
17,060
35,769
33,727
UnitedHealthcare Medicare & Retirement
28,625
25,304
57,725
50,778
UnitedHealthcare Community & State
15,666
13,110
31,206
26,083
Optum Health
$17,583
$13,300
$34,265
$25,703
Optum Insight
3,282
2,957
6,501
5,809
Optum Rx
24,805
22,524
48,716
44,128
Optum eliminations
(588)
(478)
(1,141)
(953)
(a)Earnings from operations for Optum for the three and six months ended June 30, 2022 included $1,399 and $2,765 for Optum Health; $839 and $1,686 for Optum Insight; and $1,044 and $1,983 for Optum Rx, respectively. Earnings from operations for Optum for the three and six months ended June 30, 2021 included $1,128 and $2,090 for Optum Health; $762 and $1,541 for Optum Insight; and $993 and $1,883 for Optum Rx, respectively.
4
UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS
UNITEDHEALTHCARE CUSTOMER PROFILE
(in thousands)
People Served
June 30, 2022
March 31, 2022
December 31, 2021
June 30, 2021
Commercial - Domestic:
Risk-based
8,010
7,950
7,985
7,840
Fee-based
18,480
18,460
18,595
18,395
Total Commercial - Domestic
26,490
26,410
26,580
26,235
Medicare Advantage
6,945
6,890
6,490
6,385
Medicaid
7,990
7,810
7,655
7,130
Medicare Supplement (Standardized)
4,355
4,355
4,395
4,390
Total Community and Senior
19,290
19,055
18,540
17,905
Total UnitedHealthcare - Domestic Medical
45,780
45,465
45,120
44,140
Commercial - Global
5,465
5,500
5,510
5,485
Total UnitedHealthcare - Medical
51,245
50,965
50,630
49,625
Supplemental Data
Medicare Part D stand-alone
3,330
3,360
3,700
3,750
OPTUM PERFORMANCE METRICS
June 30, 2022
March 31, 2022
December 31, 2021
June 30, 2021
Optum Health Consumers Served (in millions)
101
100
100
99
Optum Insight Contract Backlog (in billions)
$23.6
$22.8
$22.4
$21.3
Optum Rx Quarterly Adjusted Scripts (in millions)
357
352
353
342
Note: UnitedHealth Group served 149 million unique individuals across all businesses at June 30, 2022.
5
UNITEDHEALTH GROUP
RECONCILIATION OF NON-GAAP FINANCIAL MEASURE
(in millions, except per share data)
(unaudited)
ADJUSTED NET EARNINGS PER SHARE(a)
Three Months Ended
June 30,
Six Months Ended
June 30,
Projected
Year Ended
December 31,
2022
2021
2022
2021
2022
GAAP net earnings attributable to UnitedHealth Group common shareholders
$5,070
$4,266
$10,097
$9,128
$19,400 - $19,975
Intangible amortization
292
305
573
599
~1,200
Tax effect of intangible amortization
(72)
(75)
(141)
(146)
~(300)
Adjusted net earnings attributable to UnitedHealth Group common shareholders
$5,290
$4,496
$10,529
$9,581
$20,300 - $20,875
GAAP diluted earnings per share
$5.34
$4.46
$10.61
$9.55
$20.45 - $20.95
Intangible amortization per share
0.31
0.32
0.60
0.63
~1.25
Tax effect per share of intangible amortization
(0.08)
(0.08)
(0.15)
(0.16)
~(0.30)
Adjusted diluted earnings per share
$5.57
$4.70
$11.06
$10.02
$21.40 - $21.90
(a)Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP.
Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the Company's underlying business performance. Management believes that the use of adjusted net earnings per share provides investors and management useful information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company's acquisition activity, management believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company's revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share.
6
Attachments
Original Link
Original Document
Permalink
Disclaimer
UnitedHealth Group Inc. published this content on 15 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 July 2022 10:43:10 UTC.
UnitedHealth Group Inc. is one of the leading American suppliers of healthcare products and services. Income breaks down by activity as follows:
- health insurance (57.4%; UnitedHealthcare);
- prescription insurance plan management services (39.3%; Optum Health and Optum Rx): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- provision of computer services (3.3%; Optum Insight): consulting, development, and integration of solutions for transaction management, healthcare plan management, data processing, etc.